| Counter-regulatory renin–angiotensin system in cardiovascular disease M Paz Ocaranza, JA Riquelme, L García, JE Jalil, M Chiong, RAS Santos, ... Nature Reviews Cardiology 17 (2), 116-129, 2020 | 587 | 2020 |
| Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat MP Ocaranza, I Godoy, JE Jalil, M Varas, P Collantes, M Pinto, M Roman, ... Hypertension 48 (4), 572-578, 2006 | 324 | 2006 |
| ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension E Mendoza-Torres, A Oyarzún, D Mondaca-Ruff, A Azocar, PF Castro, ... Therapeutic advances in cardiovascular disease 9 (4), 217-237, 2015 | 185 | 2015 |
| Cardiac hypertrophy: molecular and cellular events JE Carreño, F Apablaza, MP Ocaranza, JE Jalil Revista Española de Cardiología (English Edition) 59 (5), 473-486, 2006 | 154 | 2006 |
| Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro MP Ocaranza, S Lavandero, JE Jalil, J Moya, M Pinto, U Novoa, ... Journal of hypertension 28 (5), 1054-1064, 2010 | 130 | 2010 |
| Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis MP Ocaranza, J Moya, V Barrientos, R Alzamora, D Hevia, C Morales, ... Journal of hypertension 32 (4), 771-783, 2014 | 128 | 2014 |
| Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients CB Stehr, R Mellado, MP Ocaranza, CA Carvajal, L Mosso, E Becerra, ... Journal of hypertension 28 (10), 2120-2126, 2010 | 105 | 2010 |
| Recent insights and therapeutic perspectives of angiotensin-(1–9) in the cardiovascular system MP Ocaranza, L Michea, M Chiong, CF Lagos, S Lavandero, JE Jalil Clinical science 127 (9), 549-557, 2014 | 89 | 2014 |
| Protective role of the ACE2/Ang‐(1–9) axis in cardiovascular remodeling MP Ocaranza, JE Jalil International journal of hypertension 2012 (1), 594361, 2012 | 80 | 2012 |
| Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1–9) axis in experimental hypertension MP Ocaranza, P Rivera, U Novoa, M Pinto, L Gonzalez, M Chiong, ... Journal of hypertension 29 (4), 706-715, 2011 | 75 | 2011 |
| Isoproterenol and angiotensin I-converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis MP Ocaranza, G Díaz-Araya, M Chiong, D Munoz, JP Riveros, ... Journal of cardiovascular pharmacology 40 (2), 246-254, 2002 | 59 | 2002 |
| Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension L Gonzalez, U Novoa, J Moya, L Gabrielli, JE Jalil, L García, M Chiong, ... Biochemical pharmacology 156, 357-370, 2018 | 57 | 2018 |
| Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure MP Ocaranza, L Gabrielli, I Mora, L Garcia, P McNab, I Godoy, S Braun, ... American heart journal 161 (5), 931-937, 2011 | 56 | 2011 |
| Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling J Jalil, S Lavandero, M Chiong, MP Ocaranza Revista Española de Cardiología (English Edition) 58 (8), 951-961, 2005 | 54 | 2005 |
| Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats MP Ocaranza, G Díaz-Araya, JE Carreno, D Munoz, JP Riveros, JE Jalil, ... American Journal of Physiology-Heart and Circulatory Physiology 286 (2 …, 2004 | 53 | 2004 |
| Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy L Gabrielli, JL Winter, I Godoy, P McNab, I Padilla, S Cordova, P Rigotti, ... American Journal of Hypertension 27 (6), 838-845, 2014 | 52 | 2014 |
| Angiotensin I-converting enzyme modulates neutral endopeptidase activity in the rat C Oliveri, MP Ocaranza, X Campos, S Lavandero, JE Jalil Hypertension 38 (3), 650-654, 2001 | 50 | 2001 |
| Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1–9) through an AT2R and Akt-dependent mechanism E Mendoza-Torres, JA Riquelme, A Vielma, AR Sagredo, L Gabrielli, ... Pharmacological research 135, 112-121, 2018 | 48 | 2018 |
| Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I–converting enzyme levels P Rivera, MP Ocaranza, S Lavandero, JE Jalil Hypertension 50 (4), 792-798, 2007 | 48 | 2007 |
| Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway C Sotomayor-Flores, P Rivera-Mejías, C Vásquez-Trincado, ... Cell Death & Differentiation 27 (9), 2586-2604, 2020 | 44 | 2020 |
